In a cohort study of 100 patients who recovered from COVID-19 [11], statistically significant discrimination between controls and post-COVID cases was reported using C-reactive protein (CRP), a blood biomarker that positively correlates with the incidence of thrombosis. This evidence concerns the gene CRP and Venous thrombosis.